Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDI vs DPI in newly diagnosed asthma
NCT07232264Completed
- Start
- Mar 2025
- Primary completion
- Sep 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of beclometasone dipropionate + formoterol in asthma (2 arms). Primary endpoint: Change in Forced Expiratory Volume in 1 second at 1 month. Started Mar 2025; status: completed.
02
Drugs
beclometasone dipropionate + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT07232264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07232264.